ABCB1 and leukemia: The most effective compound, dihydroxyquingdainone with an AC50 of 7.5 μmole, is further characterised, revealing its ability to overcome multidrug resistance in leukaemia cells (Nalm-6/BeKa) with p-glycoprotein expression.